US Patent Number

5776957

Publication Date

7-7-1998

Abstract

Optically active nornicotine compounds as a treatment for dopamine-related conditions and disease states. Such disease states include the treatment of myasthenia gravis, Parkinson's disease, Alzheimer's disease, schizophrenia, eating disorders, ulcers, drug addiction and as a substitute for psycho-stimulant self-administration.

Assignees

University of Kentucky Research Foundation, Lexington, Ky.

Application Number

749,404

Filing Date

11/15/1996

Share

COinS